Drug Shortage Report for POTASSIUM ACETATE INJECTION USP

Last updated on 2018-12-01 History
Report ID 61482
Drug Identification Number 02362597
Brand name POTASSIUM ACETATE INJECTION USP
Common or Proper name Potassium Acetate Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) POTASSIUM ACETATE
Strength(s) 39.2%
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 10 x 50 mL vial
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-09-12
Estimated end date Unknown
Actual end date 2018-11-30
Shortage status Resolved
Updated date 2018-12-01
Company comments On a 100% preventive allocation, due to the allocation on Sodium Bicarbonate.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2018-12-01 English Compare
v6 2018-11-30 French Compare
v5 2018-11-30 English Compare
v4 2018-09-14 French Compare
v3 2018-09-14 English Compare
v2 2018-09-14 French Compare
v1 2018-09-14 English Compare

Showing 1 to 7 of 7